Oxford Covid-19 vaccine is still possible this year, says AstraZeneca chief

Pharmaceutical giant’s boss says 2020 deadline possible if regulators move fast

AstraZeneca’s chief executive, Pascal Soriot, said the company’s coronavirus vaccine could still be available by the end of the year, or early next year, despite having to pause clinical trials after a volunteer fell ill.

AstraZeneca and the University of Oxford, which are jointly developing the vaccine and testing it on 50,000 to 60,000 people around the world, have had to halt trials of their vaccine to investigate the “potentially unexpected illness” of one volunteer.

Continue reading…